Peptide Storage Guide: Powder, Solution and Transport

Peptide storage comes down to two states with very different needs. Lyophilized powder is stable: −20 °C long-term, 2–8 °C short-term. Reconstituted solution is fragile: 2–8 °C, protected from light, used within a limited period. This guide brings the rules together, explains which sequences need extra care, and covers fridge, freezer and transport practice.

For laboratory research use only. The compounds discussed are not approved for human or veterinary use and are not drugs, foods or cosmetics. This article summarises published research and is not medical advice.

Key points

Powder: −20 °C long-term; 2–8 °C for weeks to months; room temperature for short transit.
Solution: 2–8 °C; do not leave it out; freeze only as single-use aliquots.
Light, moisture, agitation and freeze–thaw cycles cause most avoidable losses.
Sequence matters: Met, Cys, Trp, Asn-Gly and Asp-Pro motifs are weak points.
Label and log everything; for critical work, verify with HPLC.

Storage at a glance

Material	Long-term	Short-term	Avoid
Lyophilized powder (sealed)	−20 °C, dark, dry	2–8 °C; room temperature in transit	Humidity, opening cold vials, heat
Reconstituted solution	−20 °C single-use aliquots (sterile water)	2–8 °C, dark	Room temperature, light, shaking, repeated freezing
Bacteriostatic water (unopened)	20–25 °C	20–25 °C or 2–8 °C once opened	Freezing; use beyond 28 days after opening

Detailed guides: storing lyophilized peptides, storing reconstituted peptides and storing bacteriostatic water.

Which sequences need extra care

Chemical instability in peptides is concentrated at a handful of residues and motifs (Reubsaet et al., 1998; Manning et al., 2010). You can check a sequence against this table before deciding how conservatively to store it.

Feature in sequence	Degradation route	Mass change (MS)	Storage implication
Methionine (M)	Oxidation to sulfoxide	+16 Da	Minimise air and light; consider inert-gas headspace
Cysteine (C), free thiol	Oxidation, disulfide scrambling	−2 Da per disulfide	Store cold and dark; avoid metal contamination
Tryptophan (W)	Photo-oxidation	+4, +16, +32 Da	Strict light protection
Asn-Gly, Asn-Ser	Deamidation	+1 Da	Avoid neutral-to-basic pH in solution; keep cold
Asp-Pro, Asp-Gly	Cleavage, isomerisation	Fragmentation; 0 Da (isoAsp)	Avoid low pH and heat in solution
N-terminal Gln	Pyroglutamate formation	−17 Da	Keep solutions cold, use promptly
Long or amphipathic chain, lipid tail	Aggregation	None (seen by SEC or turbidity)	No shaking, no repeated freeze–thaw

Light deserves particular attention: photo-degradation can occur under ordinary UV-A and visible light through sensitising impurities, not only under UV lamps (Schöneich, 2020).

Fridge and freezer practice

Use the main compartment, not the door, where temperatures fluctuate most.
Keep vials away from the back wall or cooling plate of a refrigerator, where solutions can freeze unintentionally.
Prefer manual-defrost freezers for long-term powder storage; automatic defrosting warms the contents repeatedly.
Record temperatures with a min/max thermometer or data logger if samples are valuable.
Organise by lot, with the oldest material at the front.

Freezing solutions is where most damage happens. Freeze–thaw cycles concentrate solutes, shift pH and create ice interfaces, and pharmaceutical developers characterise these effects specifically to control aggregation (Jain et al., 2021). One freeze and one thaw per aliquot is the rule.

Handling habits that matter as much as temperature

Habit	Why
Warm cold powder vials before opening	Prevents condensation on hygroscopic powder
Swirl, never shake, solutions	Agitation at air–water interfaces drives aggregation, especially in dilute solutions (Treuheit et al., 2002)
Limit time out of the fridge	Room-temperature exposure accumulates
Use fine needles and swab stoppers	Reduces coring and contamination
Label solvent, concentration and date	Makes the age and history of each solution traceable

Transporting peptides

What you are moving	Recommended
Sealed lyophilized vials, short trip	Padded box, out of direct sun and heat; freeze on arrival
Sealed lyophilized vials, long or hot transit	Insulated box with cool packs
Reconstituted solutions	Insulated container at 2–8 °C; cold packs wrapped so they do not freeze the vials; upright
Frozen aliquots	Dry ice or −20 °C packs in an insulated shipper; keep frozen until use

Planning to reduce storage problems

The simplest way to avoid long storage of solutions is to reconstitute only what you will use within a reasonable period. Choose vial size and solvent volume with that in mind; the peptide reconstitution calculator helps. Our bacteriostatic water comes in a 3 mL size for smaller working volumes as well as 10 mL. For the reconstitution method itself, see how to reconstitute peptides.

Related research

Frequently asked questions

How long do peptides last in the fridge?

Sealed lyophilized powder at 2–8 °C typically keeps for months. Reconstituted solutions keep for a much shorter period, often a few weeks, depending on sequence, solvent and handling. Date every vial, and verify by HPLC when results depend on it.

What temperature should peptides be stored at?

Lyophilized powder: −20 °C long-term, 2–8 °C short-term. Reconstituted solution: 2–8 °C. Single-use frozen aliquots: −20 °C or below. All protected from light.

Do peptides expire?

Yes. Both powders and solutions degrade over time through hydrolysis, deamidation, oxidation and aggregation. Lots carry a test date and recommended retest or expiry period on the certificate of analysis.

Which peptides are most sensitive to storage conditions?

Sequences containing methionine, cysteine or tryptophan (oxidation), asparagine followed by glycine (deamidation), aspartate followed by proline (cleavage), and long or amphipathic peptides prone to aggregation.

How should peptides be transported?

Sealed lyophilized vials tolerate short unrefrigerated transit. Reconstituted solutions should travel cold (2–8 °C) in an insulated container with cold packs that do not touch the vials directly, and should not be frozen in transit.

References

Manning MC, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010. PMID: 20143256 https://pubmed.ncbi.nlm.nih.gov/20143256/
Reubsaet JL, et al. Analytical techniques used to study the degradation of proteins and peptides: chemical instability. J Pharm Biomed Anal. 1998. PMID: 9884187 https://pubmed.ncbi.nlm.nih.gov/9884187/
Jain K, et al. Freeze-thaw characterization process to minimize aggregation and enable drug product manufacturing of protein based therapeutics. Sci Rep. 2021. PMID: 34059716 https://pubmed.ncbi.nlm.nih.gov/34059716/
Schöneich C. Photo-Degradation of Therapeutic Proteins: Mechanistic Aspects. Pharm Res. 2020. PMID: 32016661 https://pubmed.ncbi.nlm.nih.gov/32016661/
Treuheit MJ, et al. Inverse relationship of protein concentration and aggregation. Pharm Res. 2002. PMID: 12033388 https://pubmed.ncbi.nlm.nih.gov/12033388/